Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Reaches Thousands of Independent Pharmacies with e-Commerce Platform

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, has more than 12,100 pharmacies currently registered as users of its proprietary Supplier-to-Pharmacy (“S2P”) e-commerce platform. An article discussing the company reads, “With the current number of users already on the network — serving an estimated 12 to 15 million patients indirectly through these member pharmacies, and adding about 100 new pharmacies per month — Trxade’s goal is to reach most, if not all, of the 24,000 independent pharmacies in the United States, which have a combined annual purchasing power of more than $92 billion. . . . Leveraging a robust technology with optimum buyer/seller pricing algorithms, product availability and predictive data analytics features, the platform is designed to help independent pharmacies identify the best available supplier prices for prescription drugs nationwide. The platform allows its members to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving them money by taking advantage of best purchase pricing.”

To view the full article, visit

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same-day or mail-order pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For more information, visit the company’s websites at, and

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS). Bookmark the permalink.

Comments are closed.